Farther Finance Advisors’s IGC Pharma IGC Stock Holding History

Farther Finance Advisors’s Portfolio IGC Stock Details IGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27	Hold	101	–	–	﹤0.01%	5892
2026 Q1	$27	Buy	101 +1	+1%	–	﹤0.01%	5626
2025 Q4	$28	Hold	100	–	–	﹤0.01%	5379
2025 Q3	$42	Buy	+100	New	+$38	﹤0.01%	4877

Other funds holding IGC

Lawood & Co Williamsport, Pennsylvania $148M AUM

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

TCM

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

Farther Finance Advisors's IGC Position: Q2 2026 in Review

Farther Finance Advisors held its IGC Pharma (IGC) position steady in Q2 2026 at 101 shares worth $27. The position accounts for ﹤0.01% of the portfolio, ranked #5892.

Farther Finance Advisors first reported a position in IGC in Q3 2025 and has held it in 4 quarters since. The position peaked at $42 in Q3 2025. 4 funds tracked by Wall St. Rank hold IGC as of Q2 2026.

Farther Finance Advisors held 101 shares of IGC Pharma worth $27 as of Q2 2026.
Farther Finance Advisors left its IGC Pharma share count unchanged in Q2 2026.
IGC Pharma made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5892 holding.
Farther Finance Advisors first reported a position in IGC Pharma in Q3 2025 and has held it in 4 quarters since.
Farther Finance Advisors's IGC Pharma position peaked at $42 in Q3 2025.
4 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.